LAB DIVISION
The InterX Lab Division is applying computational and structural techniques to understanding critical biological problems. Through understanding, we gain insights and control over these processes. Our current focus is on developing new therapies for combating cancer by leveraging our in-depth knowledge of transcriptional regulation with the novel computational and structural methods developed in InterX.

DEVELOPMENT DIVISION
InterX Development Division focuses on bridging the risk gap in Drug Discovery from drug targets to novel candidates. The Development Division applies InterX’s proprietary computer-aided drug design platform, while developing collaborations with Research Centers, Pharma companies, Start-ups, Academia and Accelerators. Such collaborations help distill the drug discovery process – from target identification to lead optimization.

Contact supplier

Stay in the loop!